At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 13 enrolled
Drug / intervention
Bacteriotherapybiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bacteriotherapy in Pediatric Inflammatory Bowel Disease
In Brief
A Phase 1 clinical trial evaluating Bacteriotherapy for Inflammatory Bowel Disease and 3 related conditions. Completed, enrolled 13 participants across 1 site.
Detailed Summary
In this study, the investigators want to see if Bacteriotherapy (also referred to as stool transplantation) improves the symptoms and decreases inflammation in children with Inflammatory Bowel Disease (IBD). Examples of IBD are Crohn's Disease and Ulcerative Colitis. Additionally, researchers want to learn whether this experimental therapy delays the need for starting additional medications to treat pediatric IBD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis, CD
CountriesUnited States
CollaboratorsSeattle Children's Hospital
Timeline
Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
First PostedDec 2012
Primary CompletionOct 2013
Study CompletionJan 2015
TodayJul 2026
First PostedDec 31, 2012
Enrollment StartDec 1, 2012
Primary CompletionOct 1, 2013
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 13.5 years ago
Interventions
Bacteriotherapybiological